The global market for Pharmacovigilance and Drug Safety Software is estimated at US$194.2 Million in 2023 and is projected to reach US$289.5 Million by 2030, growing at a CAGR of 5.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Pharmacovigilance and Drug Safety Software Market]( "Pharmacovigilance and Drug Safety Software Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the ADR Reporting segment, which is expected to reach US$132.7 Million by 2030 with a CAGR of a 5.4%. The Drug Safety Audits segment is also set to grow at 6.1% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $58.3 Million in 2023, and China, forecasted to grow at an impressive 5.5% CAGR to reach $50.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Pharmacovigilance and Drug Safety Software Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Pharmacovigilance and Drug Safety Software Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Pharmacovigilance and Drug Safety Software Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as AB Cube, ArisGlobal LLC, Ennov USA, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 47 Featured):
- AB Cube
- ArisGlobal LLC
- Ennov USA
- Extedo GmbH
- Online Business Applications, Inc.
- Oracle Corporation
- Sarjen Systems Pvt. Ltd.
- Sparta Systems, Inc.
- United Biosource Corporation
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Pharmacovigilance and Drug Safety Software - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 2: World 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
- Table 3: World Recent Past, Current & Future Analysis for ADR Reporting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 4: World 7-Year Perspective for ADR Reporting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 5: World Recent Past, Current & Future Analysis for Drug Safety Audits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 6: World 7-Year Perspective for Drug Safety Audits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Issue Tracking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 8: World 7-Year Perspective for Issue Tracking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 9: World Recent Past, Current & Future Analysis for Fully Integrated Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 10: World 7-Year Perspective for Fully Integrated Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 11: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 12: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 13: World Recent Past, Current & Future Analysis for BPOs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 14: World 7-Year Perspective for BPOs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 15: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 16: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 17: World Pharmacovigilance and Drug Safety Software Market Analysis of Annual Sales in US$ for Years 2014 through 2030
- Table 18: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 19: World 7-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 20: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 21: World 7-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 23: World 7-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
UNITED STATES
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 24: USA Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 25: USA 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 26: USA Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 27: USA 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 28: USA Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 29: USA 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
CANADA
- Table 30: Canada Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 31: Canada 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 32: Canada Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 33: Canada 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 34: Canada Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 35: Canada 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
JAPAN
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 36: Japan Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 37: Japan 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 38: Japan Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 39: Japan 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 40: Japan Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 41: Japan 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
CHINA
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 42: China Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 43: China 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 44: China Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 45: China 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 46: China Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 47: China 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
EUROPE
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 48: Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 49: Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
- Table 50: Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 51: Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 52: Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 53: Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 54: Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 55: Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
FRANCE
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 56: France Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 57: France 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 58: France Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 59: France 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 60: France Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 61: France 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
GERMANY
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 62: Germany Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 63: Germany 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 64: Germany Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 65: Germany 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 66: Germany Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 67: Germany 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
ITALY
- Table 68: Italy Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 69: Italy 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 70: Italy Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 71: Italy 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 72: Italy Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 73: Italy 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
UNITED KINGDOM
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 74: UK Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 75: UK 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 76: UK Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 77: UK 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 78: UK Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 79: UK 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
REST OF EUROPE
- Table 80: Rest of Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 81: Rest of Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 82: Rest of Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 83: Rest of Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 84: Rest of Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 85: Rest of Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
ASIA-PACIFIC
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 87: Asia-Pacific 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 89: Asia-Pacific 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 90: Asia-Pacific Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 91: Asia-Pacific 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
REST OF WORLD
- Table 92: Rest of World Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 93: Rest of World 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 94: Rest of World Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 95: Rest of World 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 96: Rest of World Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 97: Rest of World 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AB Cube
- ArisGlobal LLC
- Ennov USA
- Extedo GmbH
- Online Business Applications, Inc.
- Oracle Corporation
- Sarjen Systems Pvt. Ltd.
- Sparta Systems, Inc.
- United Biosource Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 197 |
| Published | July 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 194.2 Million |
| Forecasted Market Value ( USD | $ 289.5 Million |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | Global |
